Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Journal of Clinical Pharmacology
|
May 16, 2019
β<sub>2</sub> -Adrenergic Receptor Gene Affects the Heart Rate Response of β-Blockers: Evidence From 3 Clinical Studies
Mohamed H Shahin, Nihal El Rouby, Daniela J Conrado, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 3, 2023
Multivariate modeling of magnetic resonance biomarkers and clinical outcome measures for Duchenne muscular dystrophy clinical trials
Sarah Kim, Rebecca J Willcocks, Michael J Daniels, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 27, 2024
A computational tool to optimize clinical trial parameter selection in Duchenne muscular dystrophy: A practical guide and case studies
Jordan Wilk, Varun Aggarwal, Mike Pauley, et al.
Clinical Pharmacology and Therapeutics
|
August 19, 2022
Assessing the Combined Public Health Impact of Pharmaceutical Interventions on Pandemic Transmission and Mortality: An Example in SARS CoV-2
Mohamed A Kamal, Andreas Kuznik, Luyuan Qi, et al.
Clinical Pharmacology and Therapeutics
|
September 24, 2019
Development of a Disease Progression Model for Leucine-Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs
Malidi Ahamadi, Daniela J Conrado, Sreeraj Macha, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
May 26, 2019
Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy
Daniela J Conrado, Jane Larkindale, Alexander Berg, et al.
Clinical Pharmacology and Therapeutics
|
December 14, 2023
Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development
John D Davis, Marçal Bravo Padros, Daniela J Conrado, et al.
Journal of Parkinson'S Disease
|
July 16, 2019
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease
Diane Stephenson, Derek Hill, Jesse M Cedarbaum, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Journal of Clinical Pharmacology
|
May 16, 2019
β<sub>2</sub> -Adrenergic Receptor Gene Affects the Heart Rate Response of β-Blockers: Evidence From 3 Clinical Studies
Mohamed H Shahin, Nihal El Rouby, Daniela J Conrado, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 3, 2023
Multivariate modeling of magnetic resonance biomarkers and clinical outcome measures for Duchenne muscular dystrophy clinical trials
Sarah Kim, Rebecca J Willcocks, Michael J Daniels, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 27, 2024
A computational tool to optimize clinical trial parameter selection in Duchenne muscular dystrophy: A practical guide and case studies
Jordan Wilk, Varun Aggarwal, Mike Pauley, et al.
Clinical Pharmacology and Therapeutics
|
August 19, 2022
Assessing the Combined Public Health Impact of Pharmaceutical Interventions on Pandemic Transmission and Mortality: An Example in SARS CoV-2
Mohamed A Kamal, Andreas Kuznik, Luyuan Qi, et al.
Clinical Pharmacology and Therapeutics
|
September 24, 2019
Development of a Disease Progression Model for Leucine-Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs
Malidi Ahamadi, Daniela J Conrado, Sreeraj Macha, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
May 26, 2019
Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy
Daniela J Conrado, Jane Larkindale, Alexander Berg, et al.
Clinical Pharmacology and Therapeutics
|
December 14, 2023
Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development
John D Davis, Marçal Bravo Padros, Daniela J Conrado, et al.
Journal of Parkinson'S Disease
|
July 16, 2019
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease
Diane Stephenson, Derek Hill, Jesse M Cedarbaum, et al.
Page
of 3